Biotech - Press Releases

Date	Title	Company
20-Jul-2020	AMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020	Amryt
20-Jul-2020	BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN RECURRENT GLIOBLASTOMA INVESTIGATOR SPONSORED PHASE I/II STUDY ASSESSING SELECTIVE AXL INHIBITOR BEMCENTINIB	BerGenBio ASA
20-Jul-2020	Santhera to Join SIX Swiss Exchange Life Science Industry Indices	Santhera Pharmaceuticals
20-Jul-2020	Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2	BioNTech
20-Jul-2020	Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease	Sanifit
20-Jul-2020	FDA Notifies Companies, Including Puff Bar, to Remove Flavored Disposable E-Cigarettes and Youth-Appealing E-Liquids from Market for Not Having Required Authorization	U.S. Food and Drug Administration
20-Jul-2020	Patent awarded for Concarlo-developed therapeutic to tackle treatment-resistant breast cancer	Concarlo Holdings
20-Jul-2020	X-Pure GelMA Purest Modified Gelatin for Translational Medicine	Darling Ingredients Inc.
20-Jul-2020	PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million	PTC Therapeutics, Inc.
20-Jul-2020	Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test	Luminex Corporation
20-Jul-2020	New Certa Plus sinusoidal pump - a best in class, sustainable solution for shear sensitive, viscous pharmaceutical products	Watson-Marlow Fluid Technology Group
20-Jul-2020	Bergenbio Announces First Patient Dosed in Recurrent Glioblastoma Investigator Sponsored Phase I/II Study Assessing Selective AXL Inhibitor Bemcentinib	BerGenBio ASA
20-Jul-2020	Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization	Antengene Corporation
18-Jul-2020	Coronavirus (COVID-19) Update: FDA Issues First Emergency Authorization for Sample Pooling in Diagnostic Testing	U.S. Food and Drug Administration
17-Jul-2020	Lilly Confirms Date and Conference Call for Second-Quarter 2020 Financial Results Announcement	Eli Lilly and Company
17-Jul-2020	MARINOMED BIOTECH AG: CARRAGELOSE® EFFECTIVE AGAINST SARS-CoV-2 IN CELL CULTURE ASSAYS	Marinomed Biotech AG
17-Jul-2020	Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design	AstraZeneca
17-Jul-2020	PureTech Founded Entity Vor Biopharma Appoints Daniella Beckman to its Board of Directors	PureTech Health plc
17-Jul-2020	RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia	RedHill Biopharma Ltd
17-Jul-2020	Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020	Genmab